Adverse events from disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis decline by as much as 25% after the drugs are established on the market, according to data published ...

“This is the first time metabolic reprogramming has been applied to rheumatoid arthritis treatment, and we hope this approach can be expanded to other inflammatory diseases in the future ...

Beijing: A research team from north China's Tianjin University has developed a new type of injectable hydrogel that can ...